TR201716155A1 - Pharmaceutical formulation containing a corticosteroid in combination with a beta-2 agonist. - Google Patents
Pharmaceutical formulation containing a corticosteroid in combination with a beta-2 agonist. Download PDFInfo
- Publication number
- TR201716155A1 TR201716155A1 TR2017/16155A TR201716155A TR201716155A1 TR 201716155 A1 TR201716155 A1 TR 201716155A1 TR 2017/16155 A TR2017/16155 A TR 2017/16155A TR 201716155 A TR201716155 A TR 201716155A TR 201716155 A1 TR201716155 A1 TR 201716155A1
- Authority
- TR
- Turkey
- Prior art keywords
- corticosteroid
- agonist
- beta
- combination
- pharmaceutical formulation
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940124748 beta 2 agonist Drugs 0.000 title 1
- 239000003246 corticosteroid Substances 0.000 title 1
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 abstract 1
- 229960002714 fluticasone Drugs 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- DAFYYTQWSAWIGS-DEOSSOPVSA-N vilanterol Chemical compound C1=C(O)C(CO)=CC([C@@H](O)CNCCCCCCOCCOCC=2C(=CC=CC=2Cl)Cl)=C1 DAFYYTQWSAWIGS-DEOSSOPVSA-N 0.000 abstract 1
- 229960004026 vilanterol Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Mevcut buluş, solunum yolu rahatsızlıklarında kullanılmak üzere, vilanterol ve flutikazondan oluşan, kuru toz formundaki farmasötik formülasyonlara ilişkindir.The present invention relates to pharmaceutical formulations in dry powder form comprising vilanterol and fluticasone for use in respiratory ailments.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2017/16155A TR201716155A1 (en) | 2017-10-19 | 2017-10-19 | Pharmaceutical formulation containing a corticosteroid in combination with a beta-2 agonist. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2017/16155A TR201716155A1 (en) | 2017-10-19 | 2017-10-19 | Pharmaceutical formulation containing a corticosteroid in combination with a beta-2 agonist. |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201716155A1 true TR201716155A1 (en) | 2019-05-21 |
Family
ID=67954790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2017/16155A TR201716155A1 (en) | 2017-10-19 | 2017-10-19 | Pharmaceutical formulation containing a corticosteroid in combination with a beta-2 agonist. |
Country Status (1)
Country | Link |
---|---|
TR (1) | TR201716155A1 (en) |
-
2017
- 2017-10-19 TR TR2017/16155A patent/TR201716155A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120684T1 (en) | DRY DUST PREPARATION THAT CONTAINS A CORTICOSTEROIDS AND A BETA-ADRENERGIC FOR INHALATION | |
MA55571A (en) | PHARMACEUTICAL COMPOSITIONS COMPRISING N-(3,5-DIMETHOXYPHENYL)-N'-(1-METHYLETHYL)-N-[3-(1-METHYL-1H-PYRAZOL-4-YL)QUINOXALIN-6-YL]ETHANE-1, 2-DIAMINE | |
CL2015001984A1 (en) | (divisional sol. 1567-2013) combinations of active ingredients comprising pyridylethylbenzamides and other active ingredients. | |
CY1124490T1 (en) | A PROCESS FOR THE PREPARATION OF A DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC | |
CO2019008103A2 (en) | Pharmaceutical compositions for combination therapy | |
BR112019007459A2 (en) | antifungal dry powders | |
GT201400182A (en) | NEW PHARMACEUTICAL FORMULATIONS | |
BR112019001233A2 (en) | pharmaceutical formulation and use thereof | |
CL2017002214A1 (en) | Combination formulation of tesofensin and beta blocker | |
MX2015015132A (en) | Inhalable pharmaceutical compositions and the inhaler devices containing them. | |
CO2018014217A2 (en) | Pharmaceutical compositions comprising safinamide | |
CL2015002702A1 (en) | Micronized pharmaceutical compositions. | |
UY37261A (en) | COMBINED FORMULATION OF THREE ANTIVIRAL COMPOUNDS | |
TR201902687T4 (en) | Methods and systems for conditioning coarse crystalline materials. | |
TR201716155A1 (en) | Pharmaceutical formulation containing a corticosteroid in combination with a beta-2 agonist. | |
CL2018003338A1 (en) | Physiologically balanced injectable formulations of fosnetupitant. | |
PH12018502139A1 (en) | Phosphaplatin liquid formulations | |
CL2018002542A1 (en) | Na2-imp dehydrated as anti-caking agent | |
CO2017003989A2 (en) | Herbicidal composition and process to prepare it | |
TR201714728A1 (en) | Dry powder formulation containing Beta-2 Agonist and Corticosteroid. | |
TR201714893A1 (en) | Dry powder composition containing Beta-2 Agonist and Corticosteroid. | |
TR201714725A1 (en) | DRY POWDER FORMULATION WITH BETA-2 AGONIST AND ANTICOLINERGIC | |
TR201716207A2 (en) | Pharmaceutical formulations containing vilanterol and umeclidinium. | |
EP3210614A4 (en) | Composition containing thymosin beta 4, and pharmaceutical formulation comprising same | |
EA202091403A1 (en) | 2-OXO-1-PYRROLIDINYLIMIDAZOTHIAZOLE DERIVATIVES |